In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 27, No. 9 ( 2007-09), p. 2050-2057
Kurzfassung:
Induction of cellular immunity against VEGFR2 + cells by DNA vaccination blocked angiogenesis and attenuated both initiation and progression of atherosclerosis, whereas postinterventional neointima formation was enhanced indicating the prominent role of VEGFR2 + cells in cardiovascular diseases and showing the possibilities of DNA vaccination in the protection against atherosclerosis.
Materialart:
Online-Ressource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/ATVBAHA.107.143743
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2007
ZDB Id:
1494427-3